This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
JUR-003 in Adult Patients With Metastatic Prostate Cancer | MicrobiomeTrials
← Back to trials NCT07824349
JUR-003 in Adult Patients With Metastatic Prostate Cancer Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-09Est. Completion: 2030-06
Enrollment target: 210 participantsLocations START Midwest, Grand Rapids, Michigan, United States START New York, Lake Success, New York, United States SCRI Oncology Partners, Nashville, Tennessee, United States START San Antonio, San Antonio, Texas, United States Other microbiome trials you might be interested in Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Paranasal Sinus Neoplasms Nasopharyngeal Carcinoma Oropharyngeal Squamous Cell Carcinoma Hypopharyngeal Cancer Carcinoma of Larynx Oral Squamous Cell Carcinoma Salivary Gland Cancer Adenoid Cystic Carcinoma Prostate Cancer Metastatic Castration Resistant Prostate Cancer
Background:
Head and neck cancers (HNCs) account for about 5% of all cancers worldwide. They grow in the mouth, throat,…
Bethesda, United States Est. completion Oct 1, 2036
Prostate Cancer (Adenocarcinoma) Adenocarcinoma of the Prostate Metastatic Castration-resistant Prostate Cancer (mCRPC) Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Biochemical Recurrence (BCR) High-Risk Localized Prostate Cancer
This is a Phase 1/2 multicenter, multi-cohort imaging study to evaluate the safety, tolerability, and diagnostic perform…
Omaha, United States Est. completion Dec 2027
Non-small Cell Lung Cancer (NSCLC)
All subjects will receive the vaccine subcutaneously every 3 weeks x 3 with optional yearly booster vaccines up to and i…
Pittsburgh, United States Est. completion Oct 2028